{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T05:01:43Z","timestamp":1791435703540,"version":"4.3.3"},"reference-count":6,"publisher":"American Medical Association (AMA)","issue":"13","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA"],"published-print":{"date-parts":[[2022,10,4]]},"abstract":"<jats:p>This case series describes the clinical resolution of systemic symptoms and lesions, along with any adverse events, in patients with monkeypox infection who were treated with tecovirimat on a compassionate use basis.<\/jats:p>","DOI":"10.1001\/jama.2022.15336","type":"journal-article","created":{"date-parts":[[2022,8,22]],"date-time":"2022-08-22T15:32:50Z","timestamp":1661182370000},"page":"1348","source":"Crossref","is-referenced-by-count":134,"title":["Compassionate Use of Tecovirimat for the Treatment of Monkeypox Infection"],"prefix":"10.1001","volume":"328","author":[{"given":"Angel N.","family":"Desai","sequence":"first","affiliation":[{"name":"Division of Infectious Diseases, University of California Davis Medical Center, Sacramento, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"III","given":"George R.","family":"Thompson","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, University of California Davis Medical Center, Sacramento, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonja M.","family":"Neumeister","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, University of California Davis Medical Center, Sacramento, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna M.","family":"Arutyunova","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, University of California Davis Medical Center, Sacramento, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katelyn","family":"Trigg","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, University of California Davis Medical Center, Sacramento, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart H.","family":"Cohen","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, University of California Davis Medical Center, Sacramento, California"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"8","key":"jld220061r1","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1016\/S1473-3099(22)00228-6","article-title":"Clinical features and management of human monkeypox: a retrospective observational study in the UK.","volume":"22","author":"Adler","year":"2022","journal-title":"Lancet Infect Dis"},{"key":"jld220061r3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2207323","article-title":"Monkeypox virus infection in humans across 16 countries\u2014April-June 2022.","author":"Thornhill","year":"2022","journal-title":"N Engl J Med"},{"issue":"20","key":"jld220061r4","doi-asserted-by":"publisher","first-page":"13139","DOI":"10.1128\/JVI.79.20.13139-13149.2005","article-title":"An orally bioavailable antipoxvirus compound (ST-246) inhibits extracellular virus formation and protects mice from lethal orthopoxvirus challenge.","volume":"79","author":"Yang","year":"2005","journal-title":"J Virol"},{"issue":"1","key":"jld220061r5","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1056\/NEJMoa1705688","article-title":"Oral tecovirimat for the treatment of smallpox.","volume":"379","author":"Grosenbach","year":"2018","journal-title":"N Engl J Med"},{"key":"jld220061r2","unstructured":"CDC. 2022 Monkeypox outbreak global map. July 27, 2022. Accessed July 28, 2022. https:\/\/www.cdc.gov\/poxvirus\/monkeypox\/response\/2022\/world-map.html"},{"key":"jld220061r6","unstructured":"CDC. Information for healthcare providers on obtaining and using TPOXX (tecovirimat) for treatment of monkeypox. August 9, 2022. Accessed August 15, 2022. https:\/\/www.cdc.gov\/poxvirus\/monkeypox\/clinicians\/obtaining-tecovirimat.html"}],"container-title":["JAMA"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/articlepdf\/2795743\/jama_desai_2022_ld_220061_1664214350.149.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,4]],"date-time":"2022-10-04T15:09:23Z","timestamp":1664896163000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/fullarticle\/2795743"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,4]]},"references-count":6,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2022,10,4]]}},"URL":"https:\/\/doi.org\/10.1001\/jama.2022.15336","relation":{},"ISSN":["0098-7484"],"issn-type":[{"value":"0098-7484","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10,4]]}}}